Program
>
Clinical trial targeting HERV-W envelope with anti-MSRV Env neutralizing humanized IgG4 in MS

Robert Glanzman on behalf of Hans Peter Hartung

Dept. of Neurology, University Hospital, Düsseldorf, Germany


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close